278. 巨大リンパ管奇形（頚部顔面病変） Huge lymphatic malformation with cervicofacial lesion Clinical trials / Disease details
臨床試験数 : 22 / 薬物数 : 27 - (DrugBank : 7) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 63
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04409145 (ClinicalTrials.gov) | October 1, 2020 | 11/5/2020 | First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations | Open-Label, Intra Subject, Dose Escalation (Part 1) Followed by Randomized, Double Blind, Placebo Controlled (Part 2) Trial of Topical VT30 in Pts With Venous, Lymphatic or Mixed Malformations Associated With PIK3CA or TEK Genetic Mutations | Venous Malformation;Lymphatic Malformation;Venolymphatic Malformation | Drug: VT30 | Venthera, Inc., a BridgeBio company | NULL | Recruiting | 18 Years | 60 Years | All | 51 | Phase 1/Phase 2 | United States |